Exponent Acquires Chanelle Pharma from Founder Michael H Burke

Exponent Private Equity Acquires Majority Stake in H&MV Engineering

February 14, 2022

Industrial Services

Exponent Private Equity has agreed to acquire a majority stake in H&MV Engineering, a Co. Limerick-based specialist in high-voltage electrical engineering that serves data centre, renewables and utility clients across Ireland, the UK and EMEA. The investment will back management (who are reinvesting) and support international growth, expansion of design and delivery capabilities, and business development.

Exponent Invests in Kingsbridge Healthcare Group

July 9, 2024

Healthcare Services

Exponent, a European private equity firm, has agreed to invest in Kingsbridge Healthcare Group (KHG), a private healthcare provider operating hospitals and medical centres across Northern Ireland and the Republic of Ireland. The investment will fund expansion of KHG's capabilities, facilities and services while co-founders Dr. Suresh Tharma and Ashok Songra remain significant shareholders and management remains in place.

GHO Capital Acquires Majority Stake in Sterling Pharma Solutions

February 28, 2019

Pharmaceuticals

GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.

Fairfax Financial Acquires Stake in Meadow from Exponent

August 22, 2023

Food & Beverage

Exponent has sold a portion of its stake in Meadow to Fairfax Financial Holdings Limited. Fairfax takes a significant minority stake while Exponent and the Chantler family retain ownership stakes as Meadow prepares for its next phase of growth across its UK manufacturing sites.

Exponent Acquires IFF's Flavour Specialty Ingredients (FSI) Business

August 2, 2023

Food & Beverage

Exponent Private Equity agreed to acquire the Flavour Specialty Ingredients division (FSI) from International Flavors & Fragrances (IFF), a UK‑headquartered supplier of natural and aroma chemical base aromas. The carve‑out includes four manufacturing and distribution facilities across the UK, US and China, serves ~970+ clients and generates over $100 million in revenue; Exponent will back FSI to grow organically and via acquisitions.

Dechra Pharmaceuticals Acquires Med-Pharmex from DW Healthcare Partners

August 30, 2022

Veterinary

Dechra Pharmaceuticals PLC has completed the acquisition of Med-Pharmex Holdings, Inc. from DW Healthcare Partners. The deal brings a US-based, fully integrated veterinary pharmaceutical manufacturer (Med-Pharmex) into Dechra's global animal-health platform to strengthen its manufacturing capabilities and North American footprint.